Not applicableEnded earlyNCT01925573
What this trial is testing
Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
Who this might be right for
RECURRENT GLIOBLASTOMABrain Tumor
University of Maryland, Baltimore 7